CURIS, INC. Gain (Loss) on Disposition of Assets
CURIS, INC. (CRIS) reported Gain (Loss) on Disposition of Assets of $27.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-24
- CURIS, INC. gain (loss) on disposition of assets for the quarter ending 2015-09-30 was $1.00K.
- CURIS, INC. gain (loss) on disposition of assets for the quarter ending 2015-06-30 was $18.24K.
- CURIS, INC. gain (loss) on disposition of assets for the quarter ending 2015-03-31 was -$2.24K.
- CURIS, INC. gain (loss) on disposition of assets for fiscal 2025 was $27.19M.
- CURIS, INC. gain (loss) on disposition of assets for fiscal 2024 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 1 month | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 6 month as first filed | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $27.19M 10-K · filed 2026-03-24 | |||||
| 2025-11-30 | $27.20M 10-K · filed 2026-03-24 | |||||
| 2024-12-31 | $0.00 10-K · filed 2026-03-24 | |||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 | |||||
| 2015-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $19.24K derived: sum of 2 quarters · filed 2016-11-03 | $17.00K 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | $18.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $16.00K 10-Q · filed 2016-08-04 | $16.55K 10-Q · filed 2015-08-06 | |||
| 2015-03-31 | -$2.24K 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |